Publications by authors named "Ingeborg Wildfang"

Claim this Profile
D
Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors.
Dirk Rades, Katja Freundt, Thekla Meyners, Amira Bajrovic, Hiba Basic, Ingeborg Wildfang

Int J Radiat Oncol Biol Phys· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical innovations of carinal resection for nonsmall-cell lung cancer.
Paolo Macchiarini, Matthias Altmayer, Tetsuhiko Go, Thorsten Walles, Karl Schulze, Ingeborg Wildfang

Ann Thorac Surg· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.
Dirk Rades, Fabian Fehlauer, Rainer Schulte, Theo Veninga, Lukas J A Stalpers, Ingeborg Wildfang

J Clin Oncol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study.
Dirk Rades, Silke Tribius, Emre F Yekebas, Roia Bahrehmand, Ingeborg Wildfang

Int J Radiat Oncol Biol Phys· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study.
Dirk Rades, Jochen Walz, Lukas J A Stalpers, Theo Veninga, Rainer Schulte, Ingeborg Wildfang

Eur Urol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.
Dirk Rades, Peter J Hoskin, Lukas J A Stalpers, Rainer Schulte, Philip Poortmans, Ingeborg Wildfang

Int J Radiat Oncol Biol Phys· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study.
Dirk Rades, Fabian Fehlauer, Lukas J A Stalpers, Ingeborg Wildfang, Oliver Zschenker

Cancer· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing the overall treatment time for radiotherapy of metastatic spinal cord compression (MSCC): 3-year results of a prospective observational multi-center study.
Dirk Rades, Fabian Fehlauer, Axel Hartmann, Ingeborg Wildfang, Johann H Karstens

J Neurooncol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of epidermal growth-factor receptor in lymphangiomatosis: a new therapeutic target?
Heike Mertsching, Thorsten Walles, Gesa Bakker, Ingeborg Wildfang, Paolo Macchiarini

Lancet Oncol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis